Company Information

CIN
Status
Date of Incorporation
20 December 1994
State / ROC
Hyderabad / ROC Hyderabad
Last Balance Sheet
31 March 2023
Last Annual Meeting
27 September 2023
Paid Up Capital
350,000,000
Authorised Capital
350,000,000

Directors

Varalakshmi Mantena
Varalakshmi Mantena
Director/Designated Partner
over 2 years ago
Venkata Rama Raju Mantena
Venkata Rama Raju Mantena
Director/Designated Partner
over 2 years ago
Padmanabhuni Venkata Appaji
Padmanabhuni Venkata Appaji
Director/Designated Partner
almost 5 years ago
Venkata Raju Kalidindi
Venkata Raju Kalidindi
Director/Designated Partner
almost 5 years ago
Venkata Surya Naga Vara Prasad Raju Mantena
Venkata Surya Naga Vara Prasad Raju Mantena
Director/Designated Partner
about 13 years ago
Venkatanaga Madhusudhan Raju Mantena
Venkatanaga Madhusudhan Raju Mantena
Director/Designated Partner
over 13 years ago
Anand Mantena
Anand Mantena
Director/Designated Partner
over 14 years ago
Ashok Srinivasa Raju Mantena
Ashok Srinivasa Raju Mantena
Director/Designated Partner
over 27 years ago

Past Directors

Badri Krishnaswami
Badri Krishnaswami
Cfo(kmp)
almost 5 years ago
Sreehari Varma Kothapalli
Sreehari Varma Kothapalli
Additional Director
almost 5 years ago
Aravinda Rao Karanam
Aravinda Rao Karanam
Additional Director
almost 9 years ago
Jagadeeswaravarma Raju Vegesana
Jagadeeswaravarma Raju Vegesana
Cfo(kmp)
over 11 years ago
Venkata Ramaraju Gardiraju
Venkata Ramaraju Gardiraju
Additional Director
over 12 years ago
Venkatachelam Samba Murthy Perinkolam
Venkatachelam Samba Murthy Perinkolam
Director
about 14 years ago
Krishnam Raju Manthena
Krishnam Raju Manthena
Director
about 19 years ago

Patents

A Process For The Preparation Of Benzimidazole Derivative

The present application disclosed a process for the preparation of ethyl 3-(2-((4-cyanophenylamino) methyl)-1-methyl-N-(pyridin-2-yl)-1H-benzo[d] imidazole-5-carboxamido) propionate, compound of formula II an intermediate of Dabigatran.

A Process For The Preparation Of 4 Hydroxypiperidines”

The present application disclosed a process for the preparation of 4-hydroxypiperidine compound of formula I by reducing compound of formula II with Raney Ni.

A Process For The Preparation Of Mebeverine

The present application disclosed a process for the preparation of Mebeverine and its pharmaceutically acceptable salts.

A Process For The Preparation Of 4 Hydroxybenzothioamide

The present application disclosed a process for the preparation of 4-hydroxybenzothioamide an intermediate of Febuxostat.

An Improved Process For The Preparation Of Aripiprazole Intermediates

The present application disclosed a process for the preparation of 7-(4-halobutoxy)-3,4-dihydro-2(1H)-quinolinone of formula A an intermediate of Aripiprazole. wherein, X is a halogen selected from the group consisting of chloro, bromo and iodo.

A Process For The Preparation Of 1,3 Dialkylpiperidin 4 One

The present application disclosed a process for the preparation of 1,3-dialkylpiperidin-4-one of compound of formula I and 1,3-dimethylpiperidin-4-one.

An Improved Process For The Preparation Of Selexipag Intermediates

The present application disclosed a process for the preparation of 2-halo-5,6-diphenyl-1,4-pyrazine, an intermediate of Selexipag. Wherein, X is a halogen selected from the group consisting of chloro, bromo and iodo.

A Process For The Preparation Of Mebeverine Intermediates

The present application disclosed a process for the preparation of 4-halobutyl-3,4-dimethoxybenzoateof formula A, an intermediate of Mebeverine. wherein, X is a halogen selected from the group consisting of chloro, bromo and iodo.

A Process For The Preparation Of Nebivolol Intermediates

The present application disclosed a process for the preparation of Nebivolol epoxide intermediate using enzymatic resolution.

A Process For The Preparation Of Mebeverine

The present application disclosed a process for the preparation of Mebeverine using water as a solvent.

A Process For The Purification Of Nortriptyline

The present application disclosed a process for the purification of Nortriptyline by reducing N-nitroso impurity.

A Process For The Preparation Of Brigatinib Intermediates

Abstract The present application discloses a process for the preparation of intermediates of Brigatinib.

A Process For The Preparation Of 4 Benzamido Piperidine

Abstract The present application discloses a process for the preparation of 4-benzamido piperidine.

Registered Trademarks

Device Of V Vasudha Pharma Chem

[Class : 5] Pharmaceuticals, Pharmaceutical Drugs, Pharmaceutical Preparations.

V (Logo) Vasudha Pharma Chem

[Class : 5] Pharmaceuticals, Pharmaceutical Drugs, Pharmaceutical Preparations.

V, Vasudha Pharma Chem Limited Vasudha Pharma Chem

[Class : 5] Bulk Drugs And Drugs Intermediates

Charges

280 Crore
24 August 2018
The Hongkong And Shanghai Banking Corporation Limited
50 Crore
15 June 2018
Hdfc Bank Limited
50 Crore
29 March 2018
Idfc First Bank Limited
20 Crore
16 October 2014
The Hongkong And Shanghai Banking Corporation Limited
45 Crore
10 August 2009
Hdfc Bank Limited
65 Crore
13 January 2005
Citi Bank N.a.
40 Crore
15 December 2008
Standard Chartered Bank
15 Crore
09 May 2007
Kotak Mahindra Bank
17 Crore
18 August 2010
Hdfc Bank Limited
20 Crore
09 July 2007
Export-import Bank Of India
27 Crore
09 May 2007
Icici Bank Limited
12 Crore
14 March 1997
Union Bank Of India
30 Lak
14 March 1997
Union Bank Of India
40 Lak
20 August 1999
Union Bank Of India
2 Crore
20 October 2005
Citi Bank
3 Crore
21 September 1995
Industrial Development Bank Of India
4 Crore
05 August 2021
Axis Bank Limited
30 Crore
06 April 2022
Citi Bank N.a.
0
24 August 2018
The Hongkong And Shanghai Banking Corporation Limited
0
15 June 2018
Hdfc Bank Limited
0
09 May 2007
Icici Bank Limited
0
05 August 2021
Axis Bank Limited
0
15 December 2008
Standard Chartered Bank
0
16 October 2014
The Hongkong And Shanghai Banking Corporation Limited
0
10 August 2009
Hdfc Bank Limited
0
13 January 2005
Citi Bank N.a.
0
29 March 2018
Others
0
09 July 2007
Export-import Bank Of India
0
18 August 2010
Hdfc Bank Limited
0
20 August 1999
Union Bank Of India
0
14 March 1997
Union Bank Of India
0
09 May 2007
Others
0
20 October 2005
Citi Bank
0
14 March 1997
Union Bank Of India
0
21 September 1995
Industrial Development Bank Of India
0
06 April 2022
Citi Bank N.a.
0
24 August 2018
The Hongkong And Shanghai Banking Corporation Limited
0
15 June 2018
Hdfc Bank Limited
0
09 May 2007
Icici Bank Limited
0
05 August 2021
Axis Bank Limited
0
15 December 2008
Standard Chartered Bank
0
16 October 2014
The Hongkong And Shanghai Banking Corporation Limited
0
10 August 2009
Hdfc Bank Limited
0
13 January 2005
Citi Bank N.a.
0
29 March 2018
Others
0
09 July 2007
Export-import Bank Of India
0
18 August 2010
Hdfc Bank Limited
0
20 August 1999
Union Bank Of India
0
14 March 1997
Union Bank Of India
0
09 May 2007
Others
0
20 October 2005
Citi Bank
0
14 March 1997
Union Bank Of India
0
21 September 1995
Industrial Development Bank Of India
0